November 3, 2023 — In the U.S., someone has a stroke every 40 seconds and dies from it every three minutes and 14 seconds, according to the Centers for Disease Control and Prevention. When it comes to stroke, experts echo the fact that time is brain. Faster treatment translates to better outcomes, and certain treatments, like the clot-busting drug tPA, have a strict time window for administration. 

November 3, 2023 — The American Heart Association will present its 2023 Research Achievement Award to Marlene Rabinovitch, M.D., of Stanford University. The Research Achievement Award will be recognized during the Presidential Session on Sunday, Nov.

November 3, 2023 — The national Board of Directors of the American Heart Association last week voted to provide full support to the House of Cardiology’s consortium proposal to create a new American Board of Cardiovascular Medicine (ABCVM) specifically to certify cardiovascular physicians.

In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and cause cell death. Radiofrequency ablation (RFA) treatment uses energy to heat the tissue until it dies, resulting in its inability to transmit electrical signals that trigger arrhythmias. Cryoballoon ablation (CBA) uses a super-cooled balloon at the end of a catheter to freeze the tissue for the same result. Thermal methods for ablation have been successfully used for years; however, these methods carry uncommon yet serious risks.

The Latest Developments in Cardiac Ablation

November 2, 2023 — The latest STRIKE-PE data, presented by Penumbra, Inc. at the Vascular Interventional Advances Conference, VIVA23, showed that computer assisted vacuum thrombectomy (CAVT) for the treatment of pulmonary embolism is safe and effective at reducing right heart strain, and also improved clinical and functional outcomes.

November 2, 2023 — The University of Maryland Medical Center (UMMC) released a statement on the passing of a patient with terminal heart disease who received the world’s second genetically-modified pig heart transplant. DAIC is sharing the October 31 statement in its entirety below.

November 2, 2023 — Contego Medical Inc. announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual Vascular InterVentional Advances, VIVA 23, being held by the Viva Foundation Oct. 30-Nov.

November 2, 2023 — The second round of late-breaking clinical trials results from the Vascular InterVentional Advances Conference, VIVA23, have been announced, with results from three trial outcomes presented in the Oct. 31 afternoon session.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now